The role of dopamine and serotonin in suicidal behaviour and aggression

Progress in Brain Research

Volumn 172, Issue , 2008, Pages 307-315

  Ryding, Erik ^a,b   Lindström, Mats ^b   Träskman Bendz, Lil ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

aggression; dopamine; serotonin; suicide

Indexed keywords

DOPAMINE; SEROTONIN; SEROTONIN RECEPTOR;

AGGRESSION; BRAIN FUNCTION; BRAIN REGION; COPING BEHAVIOR; DEPRESSION; HUMAN; MOOD DISORDER; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUICIDAL BEHAVIOR; SUICIDAL IDEATION;

AGGRESSION; ANIMALS; BRAIN; DEPRESSION; DOPAMINE; HUMANS; RISK FACTORS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SUICIDE;

EID: 50349092194     PISSN: 00796123     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0079-6123(08)00915-1     Document Type: Review

References (109)

1. Agren M., Mefford I.N., Rudorfer M.V., Linnoila M., and Potter W.Z. Interacting neurotransmitter systems. A non-experimental approach to the 5HAA-HVA correlation in human CSF. J. Psychiatr. Res. 20 3 (1986) 175-193
2. Apter A., van Praag H.M., Plutchnik R., Sevy S., Korn M., and Brown S.L. Interrelationships among anxiety, aggression, impulsivity, and mood: a serotonergically linked cluster?. Psychiatry Res. 32 2 (1990) 191-199
3. Arango V., Huang Y.Y., Underwood M.D., and Mann J.J. Genetics of the serotonergic system in suicidal behavior. J. Psychiatr. Res. 37 5 (2003) 375-386
4. Arango V., Underwood M.D., and Mann J.J. Postmortem findings in suicide victims. Implications for in vivo imaging studies. Ann. N. Y. Acad. Sci. 836 (1997) 269-287
5. Arató M., Frecska E., MacCrimmon D.J., Guscott R., Saxena B., Tekes K., and Tothfalusi L. Serotonergic interhemispheric asymmetry: neurochemical and pharmaco-EEG evidence. Prog. Neuropsychopharmacol. Biol. Psychiatry 15 6 (1991) 759-764
6. Arató M., Tekes K., Tothfalusi L., Magyar K., Palkovits M., Demeter E., and Falus A. Serotonergic split brain and suicide. Psychiatry Res. 21 4 (1987) 355-356
7. Arora R.C., and Meltzer H.Y. Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. Am. J. Psychiatry 146 6 (1989) 730-736
8. Audenaert K., Goethals I., van Laere K., Lahorte P., Brans B., Versijipt J., Vervaert M., Beelaert L., van Heeringen C., and Dierckx R. SPECT neuropsychological activation procedure with the Verbal Fluency Testing in attempted suicide patients. Nucl. Med. Commun. 23 9 (2002) 907-916
9. Audenaert K., van Laere K., Dumont F., Slegers G., Mertens J., van Heeringen C., and Dierckx R. Decreased frontal serotonin 5-HT 2a receptor binding index in deliberate self-harm patients. Eur. J. Nucl. Med. 28 2 (2001) 175-182
10. Baca-Garcia E., Vaquero C., Diaz-Sastre C., Garcia-Resa E., Saiz-Ruiz J., Fernandez-Piqueras J., and de Leon J. Lack of association between the serotonin transporter promoter gene polymorphism and impulsivity or aggressive behavior among suicide attempters and healthy volunteers. Psychiatry Res. 126 2 (2004) 99-106
11. Bah J., Lindström M., Westberg L., Mannerås L., Ryding E., Henningsson S., Melke J., Rosén I., Träskman-Bendz L., and Eriksson E. Serotonin transporter gene polymorphisms: effect on serotonin transporter availability in the brain of suicide attempters. Psychiatry Res. 162 3 (2008) 221-229
12. Bannai M., Fish E.W., Faccidomo S., and Miczek K.A. Anti-aggressive effects of agonists at 5-HT(1B) receptors in the dorsal raphe nucleus of mice. Psychopharmacology (Berl.) 193 2 (2007) 295-304
13. Berlin H., Rolls E., and Kischka U. Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain 127 5 (2004) 1108-1126
14. Bernard B.K. Aggression and the brain monoamines: what are the answers, but of more importance what are the questions ...?. Natl. Inst. Drug Abuse Res. Monogr. Ser. 12 3 (1975) 71-84
15. 11C]raclopride study with amphetamine. J. Neurosci. 27 15 (2007) 3998-4003
16. Bonhomme N., and Esposito E. Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review. J. Clin. Psychopharmacol. 18 6 (1998) 447-454
17. Brunswick D.J., Amsterdam J.D., Mozley P.D., and Newberg A. Greater availability of brain dopamine transporters in major depression shown by [99mTc]TRODAT-1 SPECT imaging. Am. J. Psychiatry 160 10 (2003) 1836-1841
18. Buchsbaum M.S., Coursey R.D., and Murphy D.L. The biochemical high-risk paradigm: behavioral and familial correlates of low platelet monoamine oxidase activity. Science 194 4262 (1976) 339-341
19. Busch K.A., Fawcett J., and Jacobs D.G. Clinical correlates of inpatient suicide. J. Clin. Psychiatry 64 1 (2003) 14-19
20. Caspi A., McClay J., Moffitt T.E., Mill J., Martin J., Craig I.W., Taylor A., and Poulton R. Role of genotype in the cycle of violence in maltreated children. Science 297 5582 (2002) 851-854
21. Caspi A., Sugden K., Moffitt T.E., Taylor A., Craig I.W., Harrington H., McClay J., Mill J., Martin J., Braithwaite A., and Poulton R. Influence of the life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301 5631 (2003) 386-389
22. Coccaro E.F., Siever L.J., Klar H.M., Maurer G., Cochrane K., Cooper T.B., Mohs R.C., and Davis K.L. Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch. Gen. Psychiatry 47 7 (1989) 587-599
23. Correa H., Campi-Azevedo A.C., De Marco L., Boston W., Viana M.M., Guimaraes M.M., Costa E., Miranda D.M., and Romano-Silva M.A. Familial suicide behavior: association with probands suicide attempt characteristics and 5-HTTLPR polymorphism. Acta Psychiatr. Scand. 110 6 (2004) 459-464
24. Dahlstrom M., Ahonen A., Ebeling H., Torniainen P., Heikkila J., and Moilanen I. Elevated hypothalamic/midbrain serotonin (monoamine) transporter availability in depressive drug-naive children and adolescents. Mol. Psychiatry 5 5 (2000) 514-522
25. Daruna J.H., and Kent E.W. Comparison of regional serotonin levels and turnover in the brain of naturally high and low aggressive rats. Brain Res. 101 3 (1976) 489-501
26. de Almeida R.M., Rosa M.M., Santos D.M., Saft D.M., Benini Q., and Miczek K.A. 5-HT(1B) receptors, ventral orbitofrontal cortex, and aggressive behaviors in mice. Psychopharmacology (Berl.) 185 4 (2006) 441-450
27. de Boer S.F., Lesourd M., Mocaër E., and Koolhaas J.M. Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-1000635. Neuropsychopharmacology 23 1 (2000) 20-23
28. de Leo D., Padoani W., Lonnqvist J., Kerkhof A.J., Bille-Brahe U., Michel K., Salander-Renberg E., Schmidtke A., Wasserman D., Caon F., and Scocco P. Repetition of suicidal behaviour in elderly Europeans: a prospective longitudinal study. J. Affect. Disord. 72 3 (2002) 291-295
29. Demeter E., Tekes K., Majorossy K., Palkovits M., Soos M., Magyar K., and Somogyi E. The asymmetry of 3H-imipramine binding may predict psychiatric illness. Life Sci. 44 19 (1989) 1403-1410
30. Denson T.F., Aviles F.E., Pollock V.E., Earleywine M., Vasquez E.A., and Miller N. The effects of alcohol and the salience of aggressive cues on triggered displaced aggression. Aggress. Behav. 34 1 (2008) 25-33
31. Du L., Faludi G., Palkovits M., Sotonyi P., Bakish D., and Hrdina P.D. High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 13 9 (2002) 1195-1198
32. Dumais A., Lesage A.D., Alda M., Rouleau G., Dumont M., Chawky N., Roy M., Mann J.J., Benkelfat C., and Tureki G. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am. J. Psychiatry 162 11 (2005) 2116-2124
33. Engström G., Alling C., Blennow K., Regnéll G., and Träskman-Bendz L. Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls. Neuropsychopharmacology 9 5 (1999) 399-405
34. Esposito E. Serotonin-dopamine interaction as focus of novel antidepressant drugs. Curr. Drug Targets 7 2 (2006) 177-185
35. Fazel S., Grann M., Ahlner J., and Goodwin G. Suicides with violent means in individuals taking SSRIs and other antidepressants: a postmortem study in Sweden, 1992-2004. J. Clin. Psychopharmacol. 27 5 (2007) 503-506
36. Ferrari P.F., van Erp A.M., Tornatzky W., and Miczek K.A. Accumbal dopamine and serotonin in anticipation of the next aggressive episode in rats. Eur. J. Neurosci. 17 2 (2003) 371-378
37. Fish E.W., Faccidomo S., and Miczek K.A. Aggression heightened by alcohol or social instigation in mice: reduction by the 5-HT(1B) receptor agonist CP-94,253. Psychopharmacology (Berl.) 146 4 (1999) 391-399
38. 11C]McN 5652. Am. J. Psychiatry 162 5 (2005) 915-923
39. Geracioti T.D., Loosen P.T., Ekhator N.N., Schmidt D., Chambliss B., Baker D.G., Kasckow J.W., Richtand N.M., Keck P.E., and Ebert M.H. Uncoupling of serotonergic and noradrenergic systems in depression: preliminary evidence from continuous cerebrospinal fluid sampling. Depress. Anxiety 6 3 (1997) 89-94
40. Gerevich J., Bácskai E., and Csobor P. Aggression levels in treatment seeking inpatients with alcohol related problems compared to levels in the general population in Hungary. J. Nerv. Ment. Dis. 195 8 (2007) 669-672
41. Gibbons R.D., Hur K., Bhaumik D.K., and Mann J.J. The relationship between antidepressant medication use and the rate of suicide. Arch. Gen. Psychiatry 62 2 (2005) 165-172
42. Gibbons R.D., Hur K., Bhaumik D.K., and Mann J.J. The relationship between antidepressant prescription rates and rate of early adolescent suicide. Am. J. Psychiatry 163 11 (2006) 1898-1904
43. Goldstein R.Z., Alia-Klein N., Leskovjan A.C., Fowler J.S., Wang G.J., Gur R.C., Hitzemann R., and Volkow N.D. Anger and depression in cocaine addiction: association with the orbitofrontal cortex. Psychiatry Res. 138 1 (2005) 13-22
44. Gross-Isserdorff R., Israeli M., and Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post mortem: effects of suicide. Arch. Gen. Psychiatry 46 3 (1989) 237-241
45. Hall W.D., and Lucke J. How have the selective serotonin reuptake inhibitor antidepressants affected suicide mortality?. Aust. N. Z. J. Psychiatry 40 11-12 (2006) 941-950
46. Helbecque N., Sparks D.L., Hunsaker Jr. J.C., and Amouyel P. The serotonin transporter promoter polymorphism and suicide. Neurosci. Lett. 400 1-2 (2006) 13-15
47. Hrdina P.D., Demeter E., Vu T.B., Sotonyi P., and Palkovits M. 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res. 614 1-2 (1993) 37-44
48. Isacsson G., Holmgren P., Wasserman D., and Bergman U. Use of antidepressants among people committing suicide in Sweden. BMJ 308 6927 (1994) 506-509
49. Jackson M.E., and Moghaddam B. Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. J. Neurosci. 21 2 (2001) 676-681
50. Keilp J.G., Gorlyn M., Oquendo M.A., Brodsky B., Ellis S.P., Stanley B., and John Mann J. Aggressiveness, not impulsiveness or hostility, distinguishes suicide attempters with major depression. Psychol. Med. 36 12 (2006) 1779-1788
51. Koerts J., Lendeers K.L., Konig M., Portman A.T., and van Beilen M. Striatal dopaminergic activity (FDOPA-PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease. Eur. J. Neurosci. 25 10 (2007) 3132-3136
52. Kostowski W., Cxlonkowski A., Markowdka L., and Markiewicz L. Intraspecific aggressiveness after lesions of midbrain raphe nuclei in rats. Pharmacology 13 1 (1975) 81-85
53. Kuo W.H., Gallo J.J., and Tien A.Y. Incidence of suicide ideation and attempts in adults: the 13-year follow-up of a community sample in Baltimore, Maryland. Psychol. Med. 31 7 (2001) 1181-1191
54. Laasonen-Balk T., Kuikka J., Viinamäki H., Husso-Saastamionen M., Lehtonen J., and Tiihonen J. Striatal dopamine transporter density in major depression. Psychopharmacology (Berl.) 144 3 (1999) 282-285
55. Lawrence K.M., de Paermentier F., Cheetham S.C., Crompton M.R., Katona C.L., and Horton R.W. Brain 5-HT uptake sites, labelled with [3H]paroxetine, in antidepressant-free depressed suicides. Brain Res. 526 1 (1990) 17-22
56. Leake A., Fairbairn A.F., McKeith I.G., and Ferrier I.N. Studies on the serotonin uptake binding site in major depressive disorder and control post-mortem brain: neurochemical and clinical correlates. Psychiatry Res. 39 2 (1991) 155-165
57. 11C]Methyl-L-tryptophan trapping in orbital and ventral medial prefrontal cortex of suicide attempters. Eur. Neuropsychopharmacol. 16 3 (2006) 220-223
58. Lindström M.B., Ryding E., Bosson P., Ahnlide J.A., Rosén I., and Träskman- Bendz L. Impulsivity related to brain serotonin transporter binding capacity in suicide attempters. Eur. Neuropsychopharmacol. 14 4 (2004) 295-300
59. Lowther S., de Parmentier F., Cheetham S., Crompton M., Katona C., and Horton R. 5-HT1A receptor binding sites in post-mortem brain samples from depressed suicides and controls. J. Affect. Disord. 42 2-3 (1997) 199-207
60. Malick J.B., and Barnett A. The role of serotonergic pathways in isolation-induced aggression in mice. Pharmacol. Biochem. Behav. 5 1 (1976) 55-61
61. Mann J.J. Neurobiology of suicidal behavior. Nat. Rev. Neurosci. 4 10 (2003) 819-828
62. Mann J.J., Ellis S.P., Waternaux C.M., Liu X., Oquendo M.A., Malone K.M., Brodsky B.S., Haas G.L., and Currier D. Classification trees distinguish suicide attempters in major psychiatric disorders: a model of clinical decision making. Clin. Psychiatry 69 1 (2008) 23-31
63. Mann J.J., Hyang Y.Y., Underwood M.D., Kassir S.A., Oppemheim S., Kelly T.M., Dwork A.J., and Arango V. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide. Arch. Gen. Psychiatry 57 8 (2000) 729-738
64. Mann J.J., McBride P.A., Brown R.P., Linnoila M., Leon A.C., DeMeo M., Mieczkowski T., Myers J.E., and Stanley M. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch. Gen. Psychiatry 49 6 (1992) 443-446
65. Mann J.J., Waternaux C., Haas G.L., and Malone K.M. Towards a clinical model of suicidal behavior in psychiatric patients. Am. J. Psychiatry 156 2 (1999) 181-189
66. McCloskey M.S., Ben-Zeev D., Lee R., and Coccaro E.F. Prevalence of suicidal and self-injurious behavior among subjects with intermittent explosive disorder. Psychiatry Res. 158 (2008) 248-250
67. McGirr A., Renaud J., Bureau A., Seguin M., Lesage A., and Turecki G. Impulsive aggressive behaviours and completed suicide across the life cycle: a predisposition for younger age of suicide. Psychol. Med. 38 3 (2007) 407-417
68. Meyer J.H., Houle S., Sagrati S., Carella A., Hussey D.F., Ginovart N., Goulding V., Kennedy J., and Wilson A.A. Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes. Arch. Gen. Psychiatry 61 12 (2004) 1271-1279
69. 11C]raclopride positron emission tomography study. Am. J. Psychiatry 163 9 (2006) 1594-1602
70. Miczek K.A., and de Almeida R.M. Oral drug self-administration in the home cage of mice: alcohol-heightened aggression and inhibition by the 5-HT1B agonist anpirtoline. Psychopharmacology (Berl.) 157 4 (2001) 421-429
71. 11C]raclopride. J. Affect. Disord. 101 1-3 (2007) 113-122
72. Montgomery S.A., and Åsberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
73. Neves F.S., Silveira G., Romano-Silva M.A., Malloy-Diniz L., Ferreira A.A., De Marco L., and Correa H. Is the 5-HTTLPR polymorphism associated with bipolar disorder or with suicidal behavior of bipolar disorder patients?. Am. J. Med. Genet. B Neuropsychiatr. Genet. 147 1 (2008) 114-116
74. O'Donnell L., Stueve A., and Wilson-Simmons R. Aggressive behaviors in early adolescence and subsequent suicidality among urban youths. J. Adolesc. Health 37 6 (2005) 517
75. Oreland L., Wiberg A., Asberg M., Träskman L., Sjöstrand L., Thorén P., Bertilsson L., and Tybring G. Platelet MAO activity and monoamine metabolites in cerebrospinal fluid in depressed and suicidal patients and in healthy controls. Psychiatry Res. 4 1 (1981) 21-29
76. Owen F., Chambers D.R., Cooper S.J., Crow T.J., Johnson J.A., Lofthouse R., and Poulter M. Serotonergic mechanisms in brains of suicide victims. Brain Res. 362 1 (1986) 185-188
77. Parsey R.V., Hastings R.S., Oquendo M.A., Huang Y.Y., Simpson N., Arcement J., Huang Y., Ogden R.T., Van Heertum R.L., Arango V., and Mann J.J. Lower serotonin transporter binding potential in the human brain during major depressive episodes. Am. J. Psychiatry 163 1 (2006) 52-58
78. Pitchot W., Hansenne M., and Ansseau M. Role of dopamine in non-depressed patients with a history of suicide attempts. Eur. Psychiatry 16 7 (2001) 424-427
79. Pitchot W., Hansenne M., Gonzalez Moreno A., Pinto E., Reggers J., Fuchs S., Pirard S., and Ansseau M. Reduced dopamine function in depressed patients is related to suicidal behavior but not its lethality. Psychoendocrinology 26 7 (2001) 689-696
80. Pitchot W., Reggers J., Pinto E., Hansenne M., and Ansseau M. Catecholamine and HPA axis dysfunction in depression: relationship with suicidal behavior. Neuropsychobiology 47 3 (2003) 152-157
81. Pitchot W., Reggers J., Pinto E., Hansenne M., Fuchs S., Pirard S., and Ansseau M. Reduced dopaminergic activity in depressed suicides. Psychoendocrinology 26 3 (2001) 331-335
82. Roy A. Risk factors for suicide in psychiatric patients. Arch. Gen. Psychiatry 39 9 (1982) 1089-1095
83. Ryding E., Ahnlide J.-A., Lindström M., Rosén I., and Träskman-Bendz L. Regional brain serotonin and dopamine transporter binding capacity in suicide attempters relate to impulsiveness and mental energy. Psychiatry Res. 148 2-3 (2006) 195-203
84. Sher L., Oquendo M.A., Galfalvy H.C., Grunebaum M.F., Burke A.K., Zalsman G., and Mann J.J. The relationship of aggression to suicidal behavior in depressed patients with a history of alcoholism. Addict. Behav. 30 6 (2005) 1144-1153
85. Shih J.C., Chen K., and Ridd M.J. Monoamine oxidase: from gene to behaviour. Annu. Rev. Neurosci. 22 (1999) 197-217
86. Simon G.E., and Savarino J. Suicide attempts among patients starting depression treatment with medications or psychotherapy. Am. J. Psychiatry 164 7 (2007) 1029-1034
87. Skondras M., Markianos M., Botsis A., Bistolaki E., and Christodoulou G. Platelet monoamine oxidase activity and psychometric correlates in male violent offenders imprisoned for homicide or other violent acts. Eur. Arch. Psychiatry Clin. Neurosci. 254 6 (2004) 380-386
88. Smith K., and Crawford S. Suicidal behavior among "normal" high school students. Suicide Life Threat. Behav. 16 3 (1986) 313-325
89. Soderstrom H., Blennow K., Manhem A., and Forsman A. CSF studies in violent offenders. 5-HIAA as a negative and HVA as a positive predictor for psychopathy. J. Neural Transm. 108 7 (2001) 869-878
90. Spirito A., Valeri S., Boergers J., and Donaldson D. Predictors of continued suicidal behavior in adolescents following a suicide attempt. J. Child Adolesc. Psychol. 32 2 (2003) 284-289
91. Stanley M., and Mann J.J. Increased serotonin-2 binding sites in frontal cortex of suicide victims. Lancet 1 8318 (1983) 214-216
92. 11C]cocaine images. Synapse 31 4 (1999) 290-296
93. Tiihonen J., Kuoppamäki M., Någren K., Bergman J., Eronen E., Syvälahti E., and Hietala J. Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography. Psychopharmacology 126 4 (1996) 277-280
94. Träskman L., Asberg M., Bertilsson L., and Sjöstrand L. Monoamine metabolites in CSF and suicidal behavior. Arch. Gen. Psychiatry 38 6 (1981) 631-636
95. Träskman-Bendz L., and Mann J. Biological aspects of suicidal behavior. In: Hawton K., and van Heeringen K. (Eds). The International Handbook of Suicide and Attempted Suicide (2000), Wiley, Chichester, UK 65-77
96. Tremblay P.F., Mihic L., Graham K., and Jelley J. Role of motivation to respond to provocation, the social environment, and trait aggression in alcohol-related aggression. Aggress. Behav. 33 5 (2007) 389-411
97. Tupala E., and Tiihonen J. Dopamine and alcoholism: neurological basis of ethanol abuse. Prog. Neuropsychopharmacol. Biol. Psychiatry 28 8 (2004) 1221-1247
98. Tureki G. Dissecting the suicide phenotype: the role of impulsive-aggressive behaviors. Psychiatry Neurosci. 30 6 (2005) 398-408
99. Valzelli L. Serotonergic inhibitory control of experimental aggression. Pharmacol. Res. Commun. 14 1 (1982) 1-13
100. van Erp A.M., and Miczek K.A. Aggressive behavior, increased accumbal dopamine, and decreased cortical serotonin in rats. J. Neurosci. 20 24 (2000) 9320-9325
101. van Erp A.M., and Miczek K.A. Increased accumbal dopamine during daily alcohol consumption and subsequent aggressive behavior in rats. Psychopharmacology (Berl.) 191 3 (2007) 679-688
102. van Heeringen C., Audenaert K., van Laere K., Dumont F., Slegers G., Mertens J., and Dierckx R. Prefrontal 5-HT2a receptor binding index, hopelessness and personality characteristics in attempted suicide. J. Affect. Disord. 74 2 (2003) 149-158
103. Verkes R.J., Van der Mast R.C., Kerkhof A.J., Fekkes D., Hengeveld M.W., Tuyl J.P., and Van Kempen G.M. Platelet serotonin, monoamine oxidase activity, and [3H] paroxetine binding related to impulsive suicide attempts and borderline personality disorder. Biol. Psychiatry 43 10 (1998) 740-746
104. Wasserman D., Geijer T., Sokolowski M., Frisch A., Michaelovsky E., Weizman A., Rozanov V., and Wasserman J. Association of the serotonin transporter promotor polymorphism with suicide attempters with a high medical damage. Eur. Neuropsychopharmacol. 17 3 (2007) 230-233
105. 123I]-beta-CIT SPECT imaging shows reduced brain serotonin transporter availability in drug-free depressed patients with seasonal affective disorder. Biol. Psychiatry 47 6 (2000) 482-489
106. Zalsman G., Anderson G.M., Peskin M., Frisch A., King R.A., Vekslerchik M., Sommerfeld E., Michaelovsky E., Sher L., Weizman A., and Apter A. Relationships between serotonin transporter promoter polymorphism, platelet serotonin transporter binding and clinical phenotype in suicidal and non-suicidal adolescent inpatients. J. Neural Transm. 112 2 (2005) 309-315
107. Zalsman G., Huang Y.Y., Oquendo M.A., Burke A.K., Hu X.Z., Brent D.A., Ellis S.P., Goldman D., and Mann J.J. Association of a triallelic serotonin transporter gene promoter region (5-HTTLPR) polymorphism with stressful life events and severity of depression. Am. J. Psychiatry 163 9 (2006) 1588-1593
108. Zonda T. One hundred cases of suicide in Budapest: a case-controlled psychological autopsy study. Crisis 27 3 (2006) 125-129
109. Zouk H., McGirr A., Lebel V., Benkelfat C., Roleau G., and Turecki G. The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 144 8 (2007) 996-1002